Evolv Technologies Holdings, Inc.
For the period ended Sep 30, 2024. Filed Apr 28, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Apr 28, 2025
EVLV$4.76+4.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Financial Statements
CONDENSED CONSOLIDATED BALANCE SHEETS
| September 30, 2024 | December 31, 2023 | |
|---|---|---|
| (Restated) | ||
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $46,033 | $67,162 |
| Restricted cash | 275 | 275 |
| Marketable securities | 9,960 | 51,289 |
| Accounts receivable, net of allowance for expected credit losses of $953 and $582 as of September 30, 2024 and December 31, 2023, respectively* | 34,855 | 21,547 |
| Inventory | 16,276 | 10,344 |
| Current portion of contract assets | 696 | 1,397 |
| Current portion of commission asset | 5,256 | 4,387 |
| Prepaid expenses and other current assets | 21,050 | 16,957 |
| Total current assets | 134,401 | 173,358 |
| Contract assets, noncurrent | 672 | 964 |
| Commission asset, noncurrent | 7,385 | 7,249 |
| Property and equipment, net | 120,842 | 113,161 |
| Operating lease right-of-use assets | 14,297 | 1,195 |
| Other assets | 869 | 1,202 |
| Total assets | $278,466 | $297,129 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $8,619 | $17,400 |
| Accrued expenses and other current liabilities | 17,016 | 15,703 |
| Current portion of deferred revenue | 61,649 | 46,808 |
| Current portion of operating lease liabilities | 2,191 | 1,391 |
| Total current liabilities | 89,475 | 81,302 |
| Deferred revenue, noncurrent | 23,867 | 25,149 |
| Operating lease liabilities, noncurrent | 12,372 | — |
| Contingent earn-out liability | 14,027 | 29,119 |
| Contingently issuable common stock liability | 4,312 | 6,530 |
| Public warrant liability | 5,428 | 10,889 |
| Total liabilities | 149,481 | 152,989 |
| Commitments and contingencies (Note 16) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 100,000,000 authorized at September 30, 2024 and December 31, 2023; no shares issued and outstanding at September 30, 2024 and December 31, 2023 | — | — |
| Common stock, $0.0001 par value; 1,100,000,000 shares authorized at September 30, 2024 and December 31, 2023; 158,288,746 and 151,310,080 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively | 16 | 15 |
| Additional paid-in capital | 468,041 | 444,825 |
| Accumulated other comprehensive loss | (128) | (53) |
| Accumulated deficit | (338,944) | (300,647) |
| Stockholders’ equity | 128,985 | 144,140 |
| Total liabilities and stockholders’ equity | $278,466 | $297,129 |
*Includes related party accounts receivable, net of $1.1 million and $2.2 million as of September 30, 2024 and December 31, 2023, respectively.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.